ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Clinical Significance of T Cell and B Cell Epitope Prediction as a Risk Factor of De Novo DSA Production after Kidney Transplantation

T. Kobayashi1, K. Iwasaki1, T. Tomosugi2, Y. Miwa1, M. Niemann3, E. Spierings4, K. Horimi1, Y. Matsuoka1, A. Takeda2, N. Goto2, S. Narumi2, Y. Watarai2

1Aichi Medical University School of Medicine, Nagakute, Japan, 2Nagoya Daini Red Cross Hospital, Nagoya, Japan, 3PIRCHE AG, Berlin, Germany, 4UMC Utrecht, Utrecht, Netherlands

Meeting: 2020 American Transplant Congress

Abstract number: 243

Keywords: Epitopes, HLA antibodies, Indirect pathway, Kidney transplantation

Session Information

Session Name: Kidney Chronic Antibody Mediated Rejection

Session Type: Oral Abstract Session

Date: Saturday, May 30, 2020

Session Time: 3:15pm-4:45pm

 Presentation Time: 3:15pm-3:27pm

Location: Virtual

*Purpose: Chronic antibody-mediated rejection caused by de novo DSA (dnDSA) is a major cause of graft failure. Risk prediction of dnDSA would be important for long term graft outcome. The degree of mismatch (eplet MM) in B cell epitope recognized by BCR seems to have a direct influence on DSA production. Predicted number of T cell epitopes recognized by TCR at the first step towards DSA production in T-dependent B cell activation can be assessed by PIRCHE (Predicted indirectly recognizable HLA epitopes) score. The purpose of this study was to elucidate association between eplet MM level /PIRCHE score and dnDSA production.

*Methods: 691 living donor kidney transplantations between 2008 and 2015 were enrolled in the retrospective cohort study. Patients with preformed DSA were excluded. HLA-DRB1345 and DQB1 eplet MM level and PIRCHE score (4 digit of HLA-A, B, DR and DQ) were determined by HLA matchmaker and PIRCHE-II Matching Service, respectively. dnDSA production was annually monitored from 2009 to 2018. Screening and specificity tests were conducted. MFI >1000 in LABScreen SAB was considered positive.

*Results: (1) No significant correlation between eplet MM and PIRCHE score was observed, but both were associated with classical HLA MM levels. (2) Eplet MM level was significantly related to incidence of dnDSA production (8/235 (3.4%) in eplet MM≤13 vs 92/456 (20.2%) in eplet MM≥14, p<0.001). PIRCHE score was also significantly related to dnDSA production (26/318 (8.2%) in PIRCHE≤175, 74/373 (19.8%) in PIRCHE≥176, p<0.001). Patients with low levels of both eplet MM and PIRCHE score developed dnDSA only in 4/179 (2.2%) (Table 1). (3) Multivariate analysis of Cox hazard regression model revealed that high eplet MM (p=0.0029), high PIRCHE score (p=0.034) and acute TCMR (p<0.001) were significantly associated with dnDSA production.

*Conclusions: Analysis of T cell and B cell epitopes would provide a beneficial information on individualized immunosuppression for prevention of dnDSA production.

Incidence of de novo DSA (DRB+DQB) by eplet MM level and PIRCHE score
0-13 (Eplet MM) 14-67 (Eplet MM)
0-175 (PIRCHE) 4/179 (2.2%) 22/139 (15.8%)
176-763 (PIRCHE) 4/56 (7.1%) 70/317 (22.1%)

 border=

  • Tweet
  • Email
  • Print

To cite this abstract in AMA style:

Kobayashi T, Iwasaki K, Tomosugi T, Miwa Y, Niemann M, Spierings E, Horimi K, Matsuoka Y, Takeda A, Goto N, Narumi S, Watarai Y. Clinical Significance of T Cell and B Cell Epitope Prediction as a Risk Factor of De Novo DSA Production after Kidney Transplantation [abstract]. Am J Transplant. 2020; 20 (suppl 3). https://atcmeetingabstracts.com/abstract/clinical-significance-of-t-cell-and-b-cell-epitope-prediction-as-a-risk-factor-of-de-novo-dsa-production-after-kidney-transplantation/. Accessed May 9, 2025.

« Back to 2020 American Transplant Congress

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences